Camlin Fine Sciences Board Meeting on Nov 3 to Approve Q2 Results, Rights Issue

Camlin Fine Sciences Ltd has announced a Board of Directors meeting scheduled for November 3, 2026. The primary agenda items include the consideration and approval of the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Additionally, the board will discuss a proposal for raising funds through a rights issue of equity shares or other securities, subject to necessary regulatory and statutory approvals. The company has also confirmed the closure of its trading window from October 1, 2026, to November 5, 2026, for designated persons.